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ABSTRACT 
Objectives: Suicide in older adults is a major public health issue.  Past research across the US 
adult population has linked prescription medication misuse with suicidal ideation.  No work has 
evaluated associations between prescription opioid or benzodiazepine misuse and suicidal 
ideation in older adults, and this work aimed to address that gap. 
Methods/Design: Data were from adults 50 years and older participating in the 2015-16 
National Survey on Drug Use and Health (n = 17,608).  Design-based logistic regression 
evaluated links between any past-year prescription opioid or benzodiazepine use without misuse 
or prescription misuse and past-year suicidal ideation, after controlling for sociodemographic, 
physical health,  mental health and substance use correlates associated with suicidal ideation. 
Results: After controlling for all correlates, past-year use without misuse of prescription opioids 
or benzodiazepines were not associated with past-year suicidal ideation in older adults.  In 
contrast, past-year opioid misuse (AOR = 1.84, 95% CI = 1.07-3.19) and benzodiazepine misuse 
(AOR = 2.00, 95% CI = 1.01-3.94) were significantly associated with past-year suicidal ideation, 
even after controlling for all covariates.  While 2.2% of US older adults not engaged in either 
opioid or benzodiazepine misuse reported past-year suicidal ideation, 25.4% of those who 
misused both medication classes endorsed such suicidality (AOR = 4.73, 95% CI = 2.07-10.79). 
Conclusions: Both past-year prescription opioid and benzodiazepine misuse are associated with 
past-year suicidal ideation in US older adults.  Clinicians encountering older adult patients at-risk 
for or engaged in prescription medication misuse also should screen for suicidality. 
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KEY POINTS: 
• Use without misuse of either prescription benzodiazepine or opioid medication in the past 
year was not associated with past-year suicidal ideation in adults 50 years and older, after 
controlling for correlates of suicide in this age group. 
• In contrast, past-year misuse of either prescription benzodiazepine or opioid medication was 
associated with suicidal ideation in older adults, even after controlling for the correlates of 
suicide. 
• Of those with no past-year misuse from either medication class, 2.2% reported past-year 
suicidal ideation, while 25.4% of those who misused both classes reported such ideation.   
• These results highlight the importance of screening for opioid and benzodiazepine misuse in 
older adults, with screening for suicidality warranted in those with signs of misuse, such as 
early refill requests.  
This article is protected by copyright. All rights reserved.
Short Title: Prescription Misuse and Older Adult Suicidality 
INTRODUCTION 
 In 2015, over 44,000 US residents completed suicide, making it the tenth leading cause of 
death.1  This followed increases in US age-adjusted suicide rates between 1999 and 2014 from 
10.5 to 13.0 per 100,000.2  In particular, older adult suicide is a public health problem in the US 
specifically and worldwide;3-5 while only 8.2% of the worldwide population is 65 years and 
older, they accounted for roughly 17% of completed suicides.3  While suicide rates are highest in 
women aged 45 to 64 years,2 older males evidence the greatest risk of suicide across the US 
population, with four of the five highest suicide rates in males 55 and older.1 
 Research has identified many factors associated with older adult suicidal ideation and 
behavior.  One of the most salient is psychopathology,6 particularly major depression.3,7-9  
Research in US,3 South Korean,8,9 Brazilian7 and Australian10 older adults suggests that 
psychological distress generally and major depression specifically account for the most variance 
in models examining suicidal ideation.  Other risk factors for suicidal ideation and behavior 
include male sex11 (also noted above), being divorced or widowed3 or otherwise unmarried,11 
lower household income,12 and lower educational attainment.11,13,14 Sexual minority (i.e., LGB) 
status is a robust correlate of suicide across ages, though it appears unexamined in older adults 
specifically.15 Finally, a substance use disorder (SUD) diagnosis,4,9,11,16 poorer physical health,3 
and frequent visits to the emergency department (ED)11 appear to be strong correlates of suicidal 
ideation and behavior in older adults. 
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 One unexamined potential correlate of older adult suicidal ideation is prescription drug 
misuse (PDM), which describes use of another person’s medication or use of one’s own 
medication in ways not intended by the prescribing clinician.  In adolescents, both cross-
sectional17,18 and longitudinal evidence19 link opioid and benzodiazepine PDM with suicidal 
ideation.  Work across the US adult population also supports a link between opioid PDM and 
suicidal ideation.20-22  While opioid-related mortality rates rose among US older adults from 
2006 to 2013,23 it is not clear that these increased rates were from intentional misuse.  In all, no 
research could be found on the relationship of PDM and suicidal ideation in older adults.   
Two factors suggest the importance of studying potential links between suicidal ideation 
and PDM in older adults.  First, US adults aged 55 and older are prescribed benzodiazepine 
medication at higher rates than other age groups,24,25 with opioid prescription rates that are in the 
top two among age cohorts.24  This is despite clinical recommendations against most 
benzodiazepine use in older adults26 and that opioid use should be cautiously initiated, especially 
in older adults with cognitive deficits.27  Second, benzodiazepine and opioid medication are 
commonly used in intentional overdose. Older adults have a heightened potential for accidental 
overdose28 and appear to have more lethal suicide attempts than those of younger individuals.29,30  
Thus, the evidence suggests that research is needed evaluating potential links between opioid and 
benzodiazepine PDM in older adults and suicidal ideation; work also is needed that evaluates 
potential links between use (without misuse) of these medications and suicidal ideation. This 
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study is intended to address those gaps in the literature through analyses of the 2015 and 2016 
National Survey on Drug Use and Health (NSDUH) public use files. 
Aims and Hypotheses 
 The primary aims of this work were to evaluate whether past-year prescription opioid and 
benzodiazepine use without misuse or misuse were associated with past-year suicidal ideation in 
US older adults (aged 50 and older).  We hypothesized that, after controlling for 
sociodemographic, physical health, mental health and substance use of past-year suicidal 
ideation, past-year use without misuse of either opioids or benzodiazepines would not be 
associated with suicidal ideation but that misuse of either opioids or benzodiazepines would be 
associated with suicidal ideation, given past work across the population.20 
MATERIALS AND METHODS  
The NSDUH is an annual US survey of substance use, SUD, mental health, and other 
associated behaviors.  It uses an independent, multistage probability sample, with population-
based weighting for nationally-representative and unbiased estimates.  The NSUDH assesses all 
sensitive questions (e.g., on PDM) via audio computer-assisted self-interviewing (ACASI) to 
maximize honest reporting.  The 2015-16 versions included skip-outs and consistency checks to 
promote full responding and data consistency.  Beginning in 2015, the NSDUH’s PDM 
assessment was redesigned to assess any medication use and a greater variety of PDM variables.  
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More information on the NSDUH, including on psychometrics and the 2015 redesign, is 
available elsewhere.31-34   
 
Participants 
 Participants were adults 50 years and older (n = 17,608, 40.9% of the weighted sample) 
in the 2015-16 NSDUH public use files.  Within the weighted older adult sample, 53.2% was 
female and 43.2% was 65 years and older.  The most common racial/ethnic groups were 
white/Caucasian (73.2%), African-American (10.3%), and Hispanic/Latino (10.2%); no other 
racial/ethnic group was above 4%.  Also, 2.4% identified as gay, lesbian, or bisexual.  In terms 
of educational attainment, 14.6% did not complete high school and 31.1% were 
college/university graduates.  Finally, 16.2% had household incomes below $20,000 (USD), 
while 36.5% had household incomes of $75,000 (USD) or greater. 
 
Measures 
Primary Outcome 
 The primary outcome of interest was past-year suicidal ideation.  All participants were 
asked (bolding from the NSDUH): “The next few questions are about thoughts of suicide. At 
any time in the past 12 months, that is from [date 12 months ago inserted] up to and including 
today, did you seriously think about trying to kill yourself?” Participants answering “yes” had 
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past-year suicidal ideation.  Of the 17,608 older adults, 96 (0.55%) refused to answer or provided 
bad data on this question.  A further 398 (2.2% of the older adult sample) were missing data on 
various correlates (below), leaving a total of 17,114 older adults for our analytic sample. 
Correlates 
Correlate selection drew mainly from past work on older adult suicidality,3,4,35,36 with 
additional attention to research that examined suicidal ideation and PDM.17,19,20,22  Correlates 
were grouped into sociodemographic, physical health, mental health, substance use and 
prescription use/misuse variables. 
Sociodemographic variables were: age group (restricted by the public use file to 50-64 
years or 65 and older), sex, race/ethnicity, sexual orientation (heterosexual, gay male, lesbian, 
bisexual), population density, household income, marital status, educational attainment and 
employment status.   
Physical Health Correlates were: self-reported health (excellent, very good, good, 
fair/poor), past-year cancer, past-year heart condition, number of past-year emergency 
department (ED) visits and any past-year inpatient hospitalization. 
Mental Health Correlates were: past-year major depressive episode (MDE), past-year 
serious psychological distress (SPD) and past-year level of impairment from mental health 
symptoms. Past-year MDE was assessed based on the DSM-IV,37 with good psychometrics.38  
The SPD assessment comes from the K6 assessment of nonspecific psychological distress39 for 
the worst month in the past year; scores of 12 or greater (out of 24) signify past-year SPD.31,40  
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Past-year mental health-related impairment comes from the World Health Organization’s 
Disability Assessment Scale (WHODAS), a 13-item assessment in the NSUDH.31,41 
Substance Use Correlates were a series of three-level variables patterned as no past-year 
use, past-year use without a use disorder, and past-year use disorder.  These variables captured 
past-year tobacco (non-use/use without dependence/dependence) and alcohol or marijuana (non-
use/use without disorder/abuse or dependence) use.  Past-year alcohol or marijuana abuse or 
dependence are assessed using DSM-IV criteria,37 with strong psychometrics.33  For nicotine 
dependence, either a score of 2.75 or greater on the Nicotine Dependence Syndrome Scale42 or 
needing to smoke a cigarette within 30 minutes of waking up, as assessed by the Fagerstrom Test 
of Nicotine Dependence43 qualified as dependence (among those who smoked in the past 
month).31 
Prescription Opioid and Benzodiazepine Use/Misuse: Assessment of opioid and 
benzodiazepine use or misuse occur separately in the NSDUH, with the opioid assessment in one 
module (i.e., pain relievers, such as OxyContin®, Vicodin® and hydrocodone) and the 
benzodiazepine assessment in two modules (i.e., tranquilizers and sedatives, such as Xanax®, 
Valium® or alprazolam).  To aid recall, the NSDUH used trade and generic drug names and 
medication pictures.   
Initially, past-year opioid and benzodiazepine exposure (i.e., any medical use or misuse) 
were assessed separately by asking about any use of a large number of generic and trade named 
medications in these classes.  In those with past-year exposure, past-year opioid misuse and/or 
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past-year benzodiazepine misuse were assessed.  To introduce the assessment of misuse, the 
following instruction is given: “The next question asks about using [medication class] in any way 
a doctor did not direct you to use them. [P]lease think only about your use of the drug in any way 
a doctor did not direct you to use it, including: Using it without a prescription of your own; 
Using it in greater amounts, more often, or longer than you were told to take it; Using it in any 
other way a doctor did not direct you to use it.”    
For these analyses, two three-level variables were created: past-year benzodiazepine 
use/misuse status and past-year opioid use/misuse status.  These captured, separately for 
benzodiazepines and opioids, no past-year use, use without misuse (i.e., those with exposure who 
denied misuse) and misuse. 
 
Data Analyses 
Data were clustered on primary sampling units and stratified appropriately.  An adjusted 
person-level weight (weight/2) was used to produce unbiased estimates, given use of two years 
of aggregated data.  The Taylor series linearization with adjusted degrees of freedom44,45 was 
used for the complex survey data, creating robust variance estimates. Analyses were performed 
in Stata 15.1. 
Initial analyses employed design-based univariable regressions to test the relationship 
between past-year suicidal ideation in older adults (primary outcome) and each correlate, 
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including the opioid and benzodiazepine use/misuse variables.  Correlates with a p-value of 0.25 
or lower were retained in the multivariable models that followed.46  A more stringent p-value for 
retention (e.g., 0.05) was not chosen, as it can exclude variables that account for theoretically 
important variance in multivariable models.47,48 
 Multivariable models proceeded as follows: an initial block was entered containing 
sociodemographic correlates and both of the prescription opioid or benzodiazepine use/misuse 
variables.  If a significant association between either of the opioid or benzodiazepine use/misuse 
variables and suicidal ideation remained, a further block of correlates was added in this order: 
physical health, mental health and substance use.  For the substance use variables (including 
benzodiazepine and opioid use/misuse), non-use was set as the reference. 
 
RESULTS 
Univariable Associations between Past-Year Suicidal Ideation and Correlates  
 All univariable regression results are captured in Table 1.  For sociodemographics, 
neither sex nor population density were retained in multivariable models (ps > 0.25), but 
race/ethnicity, marital status, educational attainment and employment status were retained (ps ≤ 
0.25).  Finally, lower household income, membership in the 50 to 64 age group and gay male or 
bisexual sexual orientation were significantly associated with past-year suicidal ideation (both ps 
< 0.001). 
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 For physical health, both self-reported health and past-year inpatient hospitalization were 
significantly associated with suicidal ideation (p < 0.001).  Past-year cancer was retained (ps < 
0.25), while past-year heart condition (p = 0.35) and number of past-year ED visits (p = 0.76) 
were not retained.  Also, all examined mental health variables (i.e., past-year MDE, SPD and 
mental health-related impairment) were significantly and positively associated with past-year 
suicidal ideation in older adults (ps < 0.001).  For other substance use, past-year alcohol use 
disorder, nicotine dependence, marijuana use without use disorder, and marijuana use disorder 
were significantly associated with increased odds of past-year suicidal ideation (ps < 0.001).  
Past-year alcohol use without use disorder was retained for multivariable models (p = 0.24), but 
past-year tobacco use without nicotine dependence was not (p = 0.74). 
 Finally, all four past-year benzodiazepine and opioid use/misuse variables (i.e., 
benzodiazepine use without misuse, benzodiazepine misuse, opioid use without misuse and 
opioid misuse) were significantly associated with past-year suicidal ideation in US adults aged 
50 and older (ps < 0.001).  
<<<INSERT TABLE 1 ABOUT HERE>>> 
 
Multivariable Associations between Past-Year Suicidal Ideation and Benzodiazepine or 
Opioid Use/Misuse 
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 As noted in the Methods section, initial analysis examined the association of the 
benzodiazepine and opioid use/misuse variables in a single model, controlling for 
sociodemographics.  In these models, all benzodiazepine and opioid outcomes remained 
associated with a greater likelihood of suicidal ideation in older adults.  Specifically, past-year 
benzodiazepine use without misuse (adjusted odds ratio [AOR] = 2.37, 95% confidence interval 
[CI] = 1.80-3.11, p < 0.001), benzodiazepine misuse (AOR = 4.57, 95% CI = 2.62-7.98, p < 
0.001), opioid use without misuse (AOR = 1.53, 95% CI = 1.17-1.99, p = 0.002) and opioid 
misuse (AOR = 3.91, 95% CI = 2.43-6.29, p < 0.001) were significant correlates of past-year 
suicidal ideation after controlling for sociodemographics. 
 The second model included both sociodemographic and physical health controls in 
models.  All benzodiazepine outcomes and opioid misuse remained significant correlates: 
benzodiazepine use without misuse (AOR = 2.14, 95% CI = 1.62-2.82, p < 0.001), 
benzodiazepine misuse (AOR = 4.37, 95% CI = 2.59-7.36, p < 0.001) and opioid misuse (AOR = 
3.29, 95% CI = 2.00-5.40, p < 0.001).  Opioid use without misuse (AOR = 1.26, 95% CI = 0.94-
1.67, p = 0.12) ceased to be significant, however. 
 The third model added mental health variables, and, in these models, past-year 
benzodiazepine use without misuse ceased to be significant (AOR = 1.05, 95% CI = 0.74-1.47, p 
= 0.79) and opioid use without misuse remained non-significant (AOR = 1.01, 95% CI = 0.73-
1.40, p = 0.95).  In contrast, both past-year benzodiazepine misuse (AOR = 2.18, 95% CI = 1.13-
This article is protected by copyright. All rights reserved.
Short Title: Prescription Misuse and Older Adult Suicidality 
4.20, p = 0.022) and opioid misuse (AOR = 2.23, 95% CI = 1.31-3.80, p = 0.004) remained 
significant correlates of past-year suicidal ideation in older adults. 
 A final set of models included all control variables: sociodemographics, physical health, 
mental health and substance use; this final model is captured in Table 2.  As in the third model, 
neither past-year benzodiazepine use without misuse (AOR = 1.06, 95% CI = 0.75-1.49, p = 
0.74) nor past-year opioid use without misuse (AOR = 1.00, 95% CI = 0.73-1.37, p = 0.99) were 
associated with past-year suicidal ideation.  Even after controlling for all sociodemographic, 
physical and mental health and substance use covariates, both benzodiazepine misuse (AOR = 
2.00, 95% CI = 1.01-3.94, p = 0.046) and opioid misuse (AOR = 1.84, 95% CI = 1.07-3.19, p = 
0.03) remained significantly associated with past-year suicidal ideation in older adults. 
<<<INSERT TABLE 2 ABOUT HERE>>> 
 
Past-Year Suicidal Ideation Prevalence in Older Adults as a Function of PDM 
Per Figure 1, in older adults with neither opioid nor benzodiazepine misuse, 2.2% 
endorsed past-year suicidal ideation.  Past-year misuse of only one medication class (i.e., opioids 
or benzodiazepines) was associated with roughly a 6% increase in suicidal ideation prevalence: 
8.3% and 8.8% for opioids and benzodiazepines, respectively.  In contrast, 25.4% of older adults 
with past-year misuse of both opioids and benzodiazepines reported past-year suicidal ideation. 
Multivariable logistic regression, controlling for all correlates (including use without misuse of 
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opioid or benzodiazepine medication), indicated that those with past-year opioid misuse only 
(AOR = 1.68, 95% CI = 0.96-2.93, p = 0.068) or benzodiazepine misuse only (AOR = 1.44, 95% 
CI = 0.57-3.67, p = 0.44) did not differ from those without past-year misuse in past-year suicidal 
ideation odds.  In contrast, those with past-year misuse of both opioids and benzodiazepines had 
significantly elevated odds of suicidal ideation over those with no misuse (AOR = 4.53, 95% CI 
= 1.82-11.28, p = 0.002). 
<<<INSERT FIGURE 1 ABOUT HERE>>> 
 
DISCUSSION  
Past-year prescription opioid misuse and past-year prescription benzodiazepine misuse 
were each associated with elevated odds of past-year suicidal ideation in adults 50 years and 
older, with an 84% increase in odds with opioid misuse and a 100% increase in odds with 
benzodiazepine misuse.  The significant relationships between past-year opioid or 
benzodiazepine misuse and past-year suicidal ideation remained after controlling past-year use 
without misuse from each medication class and misuse of the other medication class (i.e., opioid 
misuse was significantly associated with suicidal ideation after accounting for benzodiazepine 
misuse).  Furthermore, these models controlled for a variety of sociodemographic, substance use, 
physical health and mental health correlates of suicidal ideation, suggesting that the link between 
suicidal ideation and benzodiazepine and/or opioid misuse is robust.  These findings are also 
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consistent with past work on opioid misuse in adolescents17-19 and adults20-22 and add to the 
literature by both highlighting benzodiazepine misuse and establishing these relationships in 
older adults.   
In contrast, links between past-year suicidal ideation and past-year use without misuse of 
either opioids or benzodiazepines were not significant when known correlates of suicidality were 
included in models.  Thus, while use without misuse does not mark suicidal ideation, opioid 
and/or benzodiazepine misuse indicate the need for screening and potentially intervention to 
prevent suicide in older adults.  The SOAPP is a validated screening measure for opioid misuse 
risk49 that can aid clinician decision-making, though no such instruments exist for 
benzodiazepine misuse.   
Most notably, over one-quarter (25.4%) of those with both past-year opioid and 
benzodiazepine misuse endorsed past-year suicidal ideation, roughly triple the prevalence of 
suicidal ideation in those with only opioid misuse (8.3%) or only benzodiazepine misuse (8.8%).  
Older adults with both opioid and benzodiazepine misuse have 353% greater odds of past-year 
suicidal ideation than those without misuse, and those with co-misuse are particularly at-risk and 
likely need both significant substance use and psychiatric interventions. 
In addition, the analyses support screening for suicidal ideation in those with past-year 
MDE, SPD, or mental health-related impairment; as mental health is a well-established 
suicidality correlate,3,6 this result was expected.  Past-year alcohol or cannabis use disorders also 
were significant and robust correlates of past-year suicidality.  These factors – past-year MDE, 
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SPD, mental health-related impairment, past-year alcohol use disorder, past-year cannabis use 
disorder and past-year prescription opioid and/or benzodiazepine misuse – appear particularly 
crucial to assess in older adults, as they are both intervention targets in their own right and signal 
potential suicidal ideation.  Opioid and benzodiazepine medication each are associated with 
unintentional and intentional overdose (i.e., suicide), making assessment of their misuse 
especially important. 
 Notably, only self-reported health was significantly associated with past-year suicidal 
ideation in the final models, with increasingly poor health associated with increased suicidal 
ideation.  In part, the relative lack of significant health variables may reflect the limited variable 
choices available in the NSDUH.  Age, income, marital status, and sexual orientation were each 
associated with suicidal ideation in univariable models, with only income and marital status 
remaining significant in the final models. Younger age group (50-64), lower household income, 
divorced, or gay or bisexual male status were associated with increased odds of suicidal ideation.  
Both lower household income and divorced status are established correlates of suicidality in 
older adults,3,12 while sexual orientation needs further study in older adults specifically. 
 Clinically, these results further reinforce that benzodiazepine use in older adults should 
be generally avoided,26 though recent work found that roughly 22% of US older adults had used 
a benzodiazepine in the past year.25  Greater use of non-pharmacological therapies for anxiety or 
insomnia, like cognitive-behavioral therapy,45 may be warranted.  For opioid medication, more 
time-limited prescribing at lower dose (consistent with recent guidelines)27 may be the best 
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course, given the risks for gastrointestinal bleeding associated with older adult non-steroidal anti-
inflammatory drug (NSAID) use.26 
 
Limitations 
The NSDUH data are cross-sectional, preventing causal inference about the relationship 
between suicidal ideation and PDM in older adults.  While one variable may have influenced the 
other, both could have been related through a third factor (e.g., internalizing psychopathology).  
A second limitation was the limited availability of variables, especially those pertaining to pain 
and physical health, and these limited unassessed measures may have influenced the patterns of 
relationships with suicidal ideation.  Third, self-report bias was possible, though research 
indicates that self-report substance use data are reliable and valid;50,51 in addition, use of 
medication pictures, numerous trade and generic medication names and ACASI self-interview 
methods should reduce self-report bias.52,53  Finally, older adults in non-household settings were 
likely under-sampled, despite the efforts of the NSDUH to sample older adults in controlled 
access dwellings (e.g., assisted living).54  Rates of psychopathology, including depression,55 are 
higher in older adults in long-term care than in community-dwelling older adults, and suicidal 
ideation56 appears somewhat common in older adults in long-term care settings.  Conversely, 
medication access is restricted in these settings, potentially limiting PDM.  Given that many 
older adults reside in controlled access settings, more research is needed on PDM and suicidal 
ideation in these older adults. 
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Conclusions 
 Past-year misuse of opioid or benzodiazepine medication was associated with increased 
odds of past-year suicidal ideation in adults 50 years and older, though use without misuse of 
either medication was not.  Strikingly, 25.4% of older adults with both past-year opioid and 
benzodiazepine misuse endorsed past-year suicidal ideation.  Together, these results suggest that 
older adults need to be screened for prescription opioid and/or benzodiazepine misuse and that 
those endorsing misuse or with signs of misuse (e.g., early refill requests, inconsistent pill 
counts) also need to be screened for suicidal ideation.  Use of prescription drug monitoring 
program (PDMP) databases is also encouraged to identify potential co-use of opioid and 
benzodiazepine medication in older adults.  In addition to limiting the potential harms in older 
adults of prescription misuse, such screening could identify those at-risk for more frank suicidal 
behavior, limiting the consequences of PDM and suicidality in older adults.    
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Table 1: Univariable Relationships between Correlates/Outcomes and Suicidal Ideation 
 t SE p-value OR 95% CI 
Sociodemographics      
Age Group -4.43 0.07 < 0.001 0.57 0.44-0.74 
Race/Ethnicity -1.60 0.03 0.12 0.94 0.88-1.02 
Sex -0.84 0.10 0.41 0.91 0.73-1.14 
Population Density 0.86 0.10 0.39 1.08 0.90-1.30 
Income -6.45 0.02 < 0.001 0.83 0.78-0.88 
Marital Status 3.80 0.05 < 0.001 1.19 1.08-1.30 
Education -1.95 0.05 0.06 0.90 0.80-1.00 
Employment Status 1.85 0.05 0.07 1.09 0.99-1.19 
Sexual Orientation 3.37 0.15 0.001 1.41 1.15-1.74 
Physical Health      
Past-Year Hospitalization 6.36 0.30 < 0.001 2.31 1.77-3.00 
Self-Reported Health 7.23 0.13 < 0.001 1.74 1.49-2.03 
Past-Year Cancer  1.91 0.54 0.06 1.79 0.97-3.30 
Past-Year Heart Condition 0.94 0.20 0.35 1.17 0.83-1.66 
Past-Year Number of ED Visits 0.31 0.004 0.76 1.00 1.00-1.00 
Mental Health      
Past-Year SPD  22.71 2.67 < 0.001 20.16 15.45-26.29 
Past-Year MDE 22.92 0.01 < 0.001 11.09 8.98-13.69 
Mental Health Impairment 26.20 0.03 < 0.001 1.57 1.52-1.63 
Alcohol Use      
No Past-Year Use ----------------Reference Group--------------- 
Past-Year Use, without Use Disorder -1.19 0.12 0.24 0.84 0.64-1.12 
Past-Year Alcohol Use Disorder 6.08 0.81 <0.001 3.74 2.42-5.79 
Tobacco Use      
No Past-Year Use ----------------Reference Group--------------- 
Past-Year Use, without Dependence 0.34 0.18 0.74 1.06 0.76-1.48 
Past-Year Nicotine Dependence 5.52 0.46 <0.001 2.63 1.85-3.75 
Marijuana Use      
No Past-Year Use ----------------Reference Group--------------- 
Past-Year Use, without Use Disorder 6.58 0.33 <0.001 2.43 1.85-3.19 
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Past-Year Cannabis Use Disorder 6.39 4.14 <0.001 11.03 5.19-23.47 
Benzodiazepine Use and Misuse      
No Past-Year Use ----------------Reference Group--------------- 
Past-Year Use, without Misuse 8.27 0.41 <0.001 3.03 2.31-3.96 
Past-Year Misuse 7.66 2.53 <0.001 8.87 5.01-15.73 
Opioid Use and Misuse      
No Past-Year Use ----------------Reference Group--------------- 
Past-Year Use, without Misuse 5.37 0.25 <0.001 1.97 1.53-2.53 
Past-Year Misuse 8.51 1.64 <0.001 7.10 4.47-11.28 
Source: NSDUH, 2015-2016 cohorts. 
Abbreviations: SE = Standard Error, OR = Odds Ratio, SUD = Substance Use Disorder, SPD = 
Serious Psychological Distress, MDE = Major Depressive Episode 
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Table 2: Multivariable Relationships between Correlates/Outcomes and Suicidal Ideation 
 t SE p-value AOR 95% CI 
Sociodemographics      
Age Group 0.13 0.13 0.90 1.02 0.79-1.31 
Race/Ethnicity -2.14 0.04 0.038 0.92 0.85-0.99 
Income -3.06 0.03 0.004 0.89 0.82-0.96 
Marital Status -2.51 0.05 0.015 0.86 0.76-0.97 
Education -0.05 0.07 0.98 1.00 0.88-1.14 
Employment Status -2.09 0.06 0.042 0.88 0.77-0.99 
Sexual Orientation 0.93 0.15 0.36 1.13 0.86-1.49 
Physical Health      
Past-Year Hospitalization 1.79 0.24 0.08 1.37 0.96-1.96 
Self-Reported Health 1.34 0.09 0.19 1.12 0.95-1.32 
Past-Year Cancer  0.72 0.54 0.48 1.34 0.59-3.02 
Mental Health      
Past-Year SPD  8.23 0.80 < 0.001 4.42 3.08-6.35 
Past-Year MDE 6.00 0.06 < 0.001 2.53 1.86-3.46 
Mental Health Impairment 7.21 0.03 < 0.001 1.23 1.16-1.30 
Alcohol Use      
No Past-Year Use ----------------Reference Group--------------- 
Past-Year Use, without Use Disorder -0.24 0.15 0.81 0.96 0.70-1.32 
Past-Year Alcohol Use Disorder 2.85 0.48 0.006 1.99 1.23-3.23 
Nicotine Use      
Nicotine Dependence 0.38 0.21 0.71 1.08 0.73-1.59 
Marijuana Use      
No Past-Year Use ----------------Reference Group--------------- 
Past-Year Use, without Use Disorder 0.79 0.21 0.44 1.15 0.80-1.65 
Past-Year Cannabis Use Disorder 2.67 1.72 0.01 3.59 1.37-9.39 
Benzodiazepine Use and Misuse      
No Past-Year Use ----------------Reference Group--------------- 
Past-Year Use, without Misuse 0.33 0.18 0.74 1.06 0.75-1.49 
Past-Year Misuse 2.05 0.68 0.046 2.00 1.01-3.94 
Opioid Use and Misuse      
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No Past-Year Use ----------------Reference Group--------------- 
Past-Year Use, without Misuse 0.02 0.16 0.99 1.00 0.73-1.37 
Past-Year Misuse 2.24 0.50 0.03 1.84 1.07-3.19 
Source: NSDUH, 2015-2016 cohorts. 
Abbreviations: SE = Standard Error, OR = Odds Ratio, SUD = Substance Use Disorder, SPD = 
Serious Psychological Distress, MDE = Major Depressive Episode 
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Figure Legend 
Figure 1: Prevalence of Past-Year Suicidal Ideation by Past-Year Prescription Drug Misuse 
Status 
Notes: Error bars represent standard errors 
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